{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:18:25Z","timestamp":1792120705032,"version":"4.4.0"},"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:00:00Z","timestamp":1413417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003218","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T13:45:32Z","timestamp":1413812732000},"page":"e3218","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":155,"title":["Mycetoma Medical Therapy"],"prefix":"10.1371","volume":"8","author":[{"given":"Oliverio","family":"Welsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hail Mater","family":"Al-Abdely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Cesar","family":"Salinas-Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Hassan","family":"Fahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,16]]},"reference":[{"key":"ref1","first-page":"586","article-title":"[Update on the epidemiology of mycetoma in Mexico. A review of 3933 cases]","volume":"149","author":"R Lopez-Martinez","year":"2013","journal-title":"Gac Med Mex"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.clindermatol.2011.06.027","article-title":"Actinomycetoma and advances in its treatment","volume":"30","author":"O Welsh","year":"2012","journal-title":"Clin Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.trstmh.2010.11.008","article-title":"The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis","volume":"105","author":"AH Fahal","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.trstmh.2012.07.003","article-title":"Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan","volume":"106","author":"HA Zein","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1099\/jmm.0.042044-0","article-title":"Nocardia harenae, an uncommon causative organism of mycetoma: report on two patients","volume":"61","author":"NS Kresch-Tronik","year":"2012","journal-title":"J Med Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1346-8138.12009","article-title":"First case of mycetoma associated with Nocardia takedensis","volume":"40","author":"NS Kresch-Tronik","year":"2013","journal-title":"J Dermatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/CMR.19.2.259-282.2006","article-title":"Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy","volume":"19","author":"BA Brown-Elliott","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1128\/AAC.01520-09","article-title":"In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid","volume":"54","author":"L Vera-Cabrera","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1128\/AAC.01279-10","article-title":"Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents","volume":"55","author":"J Larruskain","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/AAC.48.3.832-837.2004","article-title":"In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis","volume":"48","author":"A Gomez-Flores","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/molecules13010031","article-title":"Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis","volume":"13","author":"NA Espinoza-Gonz\u00e1lez","year":"2008","journal-title":"Molecules"},{"key":"ref12","first-page":"183","article-title":"Experimental mycetoma by Nocardia brasiliensis in rats","volume":"8","author":"L Vera-Cabrera","year":"1998","journal-title":"Journal de mycologie m\u00e9dicale"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1471-2334-11-290","article-title":"Decrease of virulence for BALB\/c mice produced by continuous subculturing of Nocardia brasiliensis","volume":"11","author":"JA Almaguer-Ch\u00e1vez","year":"2011","journal-title":"BMC Infect Dis"},{"key":"ref14","first-page":"345","article-title":"Acci\u00f3n de la 4-4 diamino-difenil-sulfona frente a Nocardia brasiliensis (estudios in vitro en la infecci\u00f3n experimental y en cl\u00ednica)","volume":"52","author":"A Gonz\u00e1lez-Ochoa","year":"1952","journal-title":"Gac Med Mex"},{"key":"ref15","unstructured":"Latapi F, Lavalle P, editors (1954) Emploi des sulfones et de L&apos;isoniazide dans le traitment des mycetomes. VIII Congres International de Botanique; Paris, France."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4269\/ajtmh.1972.21.332","article-title":"Treatment of actinomycetoma with sulphamethoxazole plus trimethoprim","volume":"21","author":"ES Mahgoub","year":"1972","journal-title":"Am J Trop Med Hyg"},{"key":"ref17","first-page":"517","article-title":"[Mycetomas with pulmonary dissemination]","volume":"13","author":"LO Welsh","year":"1984","journal-title":"Medicina cutanea ibero-latino-americana"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1128\/JB.00210-12","article-title":"Complete genome sequence of Nocardia brasiliensis HUJEG-1","volume":"194","author":"L Vera-Cabrera","year":"2012","journal-title":"J Bacteriol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(87)70227-8","article-title":"Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma","volume":"17","author":"O Welsh","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"ref20","unstructured":"Welsh O (1989) Amikacina-Trimethoprim-Sulfamethoxazole en el tratamiento de micetoma actinomicosicos. [Doctoral thesis]. Monterrey, Mexico: Universidad Autonoma de Nuevo Leon."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1128\/AAC.45.12.3629-3630.2001","article-title":"In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis","volume":"45","author":"L Vera-Cabrera","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/AAC.00571-06","article-title":"In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis","volume":"50","author":"L Vera-Cabrera","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1128\/AAC.01023-08","article-title":"Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB\/c mice","volume":"53","author":"BE Chacon-Moreno","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.clindermatol.2011.09.009","article-title":"Eumycetoma","volume":"30","author":"R Estrada","year":"2012","journal-title":"Clin Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/AAC.9.6.956","article-title":"Ototoxicity of amikacin","volume":"9","author":"RE Black","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/infdis\/167.1.173","article-title":"Incidence of and Significant Risk Factors for Aminoglycoside-Associated Nephrotoxicity in Patients Dosed by Using Individualized Pharmacokinetic Monitoring","volume":"167","author":"JS Bertino","year":"1993","journal-title":"J Infect Dis"},{"key":"ref27","first-page":"183","article-title":"Imipenem\/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy","volume":"33","author":"SP Clissold","year":"1987","journal-title":"Drugs"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.285.10.1291","article-title":"LInezolid and reversible myelosuppression","volume":"285","author":"SL Green","year":"2001","journal-title":"JAMA"},{"key":"ref29","unstructured":"Drugs.com (2000) Linezolid Side Effects. Updated 3 April 2014. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.drugs.com\/sfx\/linezolid-side-effects.html\" xlink:type=\"simple\">http:\/\/www.drugs.com\/sfx\/linezolid-side-effects.html<\/ext-link>. Accessed 9 April 2014."},{"key":"ref30","unstructured":"Drugs.com (2000) Sulfamethoxazole\/trimethoprim Side Effects. Updated 4 April 2014. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.drugs.com\/sfx\/sulfamethoxazole-trimethoprim-side-effects.html\" xlink:type=\"simple\">http:\/\/www.drugs.com\/sfx\/sulfamethoxazole-trimethoprim-side-effects.html<\/ext-link>. Accessed 20 March 2014."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.clindermatol.2011.09.009","article-title":"Eumycetoma","volume":"30","author":"R Estrada","year":"2012","journal-title":"Clin Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1128\/JCM.05477-11","article-title":"New species of Madurella, causative agents of black-grain mycetoma","volume":"50","author":"GS de Hoog","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1128\/AAC.48.7.2742-2746.2004","article-title":"In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay","volume":"48","author":"AO Ahmed","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.49.4.1364-1368.2005","article-title":"Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method","volume":"49","author":"WW van de Sande","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/AAC.01546-09","article-title":"Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents","volume":"54","author":"WW van de Sande","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.01045-10","article-title":"In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine","volume":"55","author":"A van Belkum","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/43.1.149","article-title":"Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum","volume":"43","author":"M Cuenca-Estrella","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3314\/jjmm.45.101","article-title":"Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents","volume":"45","author":"J Zeng","year":"2004","journal-title":"Nihon Ishinkin Gakkai zasshi"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/AAC.41.4.841","article-title":"In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens","volume":"41","author":"SA Radford","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/13693780903148353","article-title":"The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species","volume":"48","author":"H Badali","year":"2010","journal-title":"Med Mycol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/02681219380000181","article-title":"Antimycotic susceptibility testing of agents of black grain eumycetoma","volume":"31","author":"PV Venugopal","year":"1993","journal-title":"J Med Vet Mycol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/AAC.48.5.1912-1915.2004","article-title":"In vitro activity of anidulafungin against selected clinically important mold isolates","volume":"48","author":"Z Odabasi","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.micinf.2007.05.015","article-title":"Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole","volume":"9","author":"WW van de Sande","year":"2007","journal-title":"Microbes and infection\/Institut Pasteur"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1128\/AAC.01170-12","article-title":"In vitro antifungal activity of isavuconazole against Madurella mycetomatis","volume":"56","author":"W Kloezen","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/AAC.46.1.62-68.2002","article-title":"In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates","volume":"46","author":"J Meletiadis","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jac\/dkh228","article-title":"In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi","volume":"53","author":"G Garcia-Effron","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1556\/AMicr.57.2010.3.5","article-title":"In vitro activity of conventional antifungal agents against Scedosporium apiospermum isolates recovered from clinical and environmental samples in Nigeria","volume":"57","author":"EI Nweze","year":"2010","journal-title":"Acta Microbiol Immunol Hung"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/AAC.45.7.2151-2153.2001","article-title":"In vitro activities of four novel triazoles against Scedosporium spp","volume":"45","author":"AJ Carrillo","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/JCM.00134-07","article-title":"Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin","volume":"45","author":"A Espinel-Ingroff","year":"2007","journal-title":"J Clin Microbiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/13693780802512451","article-title":"Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole","volume":"47","author":"AW Fothergill","year":"2009","journal-title":"Med Mycol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/13693780802713497","article-title":"The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus","volume":"48","author":"WW van de Sande","year":"2010","journal-title":"Med Mycol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/00362177885380281","article-title":"Experimental infection of athymic nude New Zealand mice, nu nu strain with mycetoma agents","volume":"16","author":"ES Mahgoub","year":"1978","journal-title":"Sabouraudia"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0928-8244(03)00096-8","article-title":"A murine model of Madurella mycetomatis eumycetoma","volume":"37","author":"AO Ahmed","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1128\/AAC.48.10.4009-4011.2004","article-title":"Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs","volume":"48","author":"J Capilla","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1128\/AAC.47.12.3976-3978.2003","article-title":"Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice","volume":"47","author":"J Capilla","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/mmy.40.3.243.248","article-title":"Experimental murine model of disseminated Pseudallescheria infection","volume":"40","author":"GM Gonzalez","year":"2002","journal-title":"Med Mycol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1128\/AAC.47.4.1436-1438.2003","article-title":"Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays","volume":"47","author":"GM Gonzalez","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/jpet.112.201541","article-title":"Experimental models of disseminated scedosporiosis with cerebral involvement","volume":"345","author":"B Lelievre","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/jac\/dkq171","article-title":"Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species","volume":"65","author":"E Calvo","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1128\/AAC.48.6.2288-2291.2004","article-title":"Posaconazole therapy of disseminated phaeohyphomycosis in a murine model","volume":"48","author":"JR Graybill","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1128\/AAC.49.5.1701-1707.2005","article-title":"Antifungal therapy of experimental cerebral phaeohyphomycosis due to Cladophialophora bantiana","volume":"49","author":"HM Al-Abdely","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1093\/jac\/dkm428","article-title":"New and emerging treatments for fungal infections","volume":"61, Suppl 1","author":"AC Pasqualotto","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1179\/joc.2008.20.6.661","article-title":"New and investigational triazole agents for the treatment of invasive fungal infections","volume":"20","author":"A De Sarro","year":"2008","journal-title":"J Chemother"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0035-9203(84)90126-3","article-title":"Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii","volume":"78","author":"ES Mahgoub","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref65","first-page":"163","article-title":"[Value of ketoconazole in combination with the surgical treatment of fungal mycetoma]","volume":"112","author":"JM Andreu","year":"1986","journal-title":"Chirurgie; memoires de l'Academie de chirurgie"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1440-0960.1993.tb00844.x","article-title":"Treatment of eumycetoma with ketoconazole","volume":"34","author":"PV Venugopal","year":"1993","journal-title":"Australas J Dermatol"},{"key":"ref67","unstructured":"Food and Drug Administration (2013) Postmarket Drug Safety Information for Patients and Providers. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm371019.htm\" xlink:type=\"simple\">http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm371019.htm<\/ext-link>. Accessed 15 July 2014."},{"key":"ref68","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1093\/clinids\/14.Supplement_1.S68","article-title":"A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group","volume":"14 Suppl 1","author":"M Diaz","year":"1992","journal-title":"Clin Infect Dis"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0190-9622(95)90437-9","article-title":"Improvement of eumycetoma with itraconazole","volume":"33","author":"BI Resnik","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"ref70","first-page":"191","article-title":"Clinical cure of fungal madura foot with oral itraconazole","volume":"60","author":"A Paugam","year":"1997","journal-title":"Cutis"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0190-9622(97)70302-5","article-title":"Improvement of eumycetoma with itraconazole","volume":"36","author":"EL Smith","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2133.2005.06534.x","article-title":"Madurella mycetomatis mycetoma treated successfully with oral voriconazole","volume":"152","author":"C Lacroix","year":"2005","journal-title":"Brit J Dermatol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4269\/ajtmh.2006.75.1106","article-title":"Successful treatment of black-grain mycetoma with voriconazole","volume":"75","author":"P Loulergue","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1590\/S0036-46652005000600006","article-title":"Posaconazole treatment of refractory eumycetoma and chromoblastomycosis","volume":"47","author":"R Negroni","year":"2005","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1086\/421020","article-title":"Exophiala jeanselmei infection in a heart transplant recipient successfully treated with oral terbinafine","volume":"38","author":"WA Agger","year":"2004","journal-title":"Clin Infec Dis"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1365-4632.2006.03077.x","article-title":"Successful treatment of subcutaneous phaeohyphomycosis owing to Exophiala jeanselmei with oral terbinafine","volume":"45","author":"E Rallis","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-4632.2004.02392.x","article-title":"Clinical efficacy and safety of oral terbinafine in fungal mycetoma","volume":"45","author":"B N'Diaye","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1439-0507.2011.02107.x","article-title":"Severe prosthetic joint infection in an immunocompetent male patient due to a therapy refractory Pseudallescheria apiosperma","volume":"54","author":"M Lackner","year":"2011","journal-title":"Mycoses"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1128\/JCM.01840-09","article-title":"Disseminated Scedosporium\/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis","volume":"48","author":"F Morio","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1346-8138.2009.00597.x","article-title":"Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole","volume":"36","author":"Y Matsumoto","year":"2009","journal-title":"J Dermatol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.transproceed.2007.05.044","article-title":"Disseminated Scedosporium apiospermum infection in renal transplant recipient: long-term successful treatment with voriconazole: a case report","volume":"39","author":"PG Rogasi","year":"2007","journal-title":"Transplantation proceedings"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/314042","article-title":"Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis","volume":"31","author":"MA Nesky","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.trstmh.2005.12.010","article-title":"Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole","volume":"100","author":"L Porte","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.01388-07","article-title":"Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients","volume":"52","author":"P Troke","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1086\/340522","article-title":"Treatment of Scedosporium apiospermum brain abscesses with posaconazole","volume":"34","author":"IK Mellinghoff","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref86","article-title":"Drugs at FDA","year":"2012","journal-title":"Itraconazole"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/08998280.2007.11928283","article-title":"Posaconazole (Noxafil): a new triazole antifungal agent","volume":"20","author":"ND Greer","year":"2007","journal-title":"Proc (Bayl Univ Med Cent)"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T06:59:26Z","timestamp":1565938766000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003218"}},"subtitle":[],"editor":[{"given":"Pamela L. C.","family":"Small","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,16]]},"references-count":87,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003218","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,16]]}}}